Scientific Reviews
Product Guides
Blogs
Topics
Targeted therapy! The Capetin Prize winning "Click Chemistry" can be used like this!Targeted therapy! The Nobel Prize winning "Click Chemistry" can be used like this!2025-02-06
10021 Results for "
Modified citrus pectin
" in MedChemExpress (MCE) Product Catalog:
Products (10021)
10021 Results for "Modified citrus pectin" in MCE Product Catalog:
8
8 Cited Publications
Cat. No.: HY-K3002
DMEM/F-12 (Dulbecco's Modified Eagle Medium/Nutrient Mixture F-12) is a widely used basal medium for supporting the growth of many different mammalian cells. Cell successfully cultured in DMEM/F-12 include MDCK, glial cells, fibroblasts, human endothelial cells, etc. The 500 mL is defined as the base specification. All larger sizes correspond to incremental volumes of this base.
7
7 Cited Publications
Cat. No.: HY-N0804
CAS No.: 14259-46-2
Category:
Rutaceae Extract Flavonoids Flavonones Phenols Polyphenols Plants Disease Research Fields Inflammation/Immunology Citrus
Target:
7
Category:
Rutaceae Extract Flavonoids Flavanols Other Diseases Plants Disease Research Fields Citrus bergamia
Target:
7
7 Cited Publications
Target:
Research Areas:
Nusinersen is an antisense oligonucleotide active molecule. Nusinersen modifies the pre-messenger RNA splicing of the SMN2 gene, thereby promoting the production of full-length SMN protein. Nusinersen improves spinal muscular atrophy .
7
7 Cited Publications
Cat. No.: HY-112980A
Purity: 98.91%
Target:
Research Areas:
Nusinersen sodium is an antisense oligonucleotide active molecule. Nusinersen sodium modifies the pre-messenger RNA splicing of the SMN2 gene, thereby promoting the production of full-length SMN protein. Nusinersen sodium improves spinal muscular atrophy .
7
7 Cited Publications
CWI1-2 is an IGF2BP2 inhibitor that binds IGF2BP2 and inhibits its interaction with m6A-modified target transcripts, induces apoptosis and differentiation, and shows promising anti-leukemic effects .
7
7 Cited Publications
CWI1-2 hydrochloride is an IGF2BP2 inhibitor that binds IGF2BP2 and inhibits its interaction with m6A-modified target transcripts, induces apoptosis and differentiation, and shows promising anti-leukemic effects .
7
Target:
Research Areas:
Madrasin (DDD00107587) is a splicing inhibitor that prevents formation of both splicing intermediates and products in vitro and interferes with one or more early steps in the pathway of spliceosome assembly. Madrasin also can inhibit pre-mRNA splicing in vitro and modify splicing of endogenous pre-mRNA in cells .
5
Category:
Plants Other Families Extract Dihydrochalcones Sweeteners Food Research Flavonoids Phenols Polyphenols Disease Research Fields Cancer
Target:
5
Target:
Research Areas:
Apramycin (Nebramycin II) is an orally active, acidic pH tolerant and aminoglycoside-modifying-enzymes-tolerant aminoglycoside antibiotic which inhibits protein biosynthesis by targeting the bacterial ribosome. Apramycin is a potential anti-drug-resistance antibiotic .
5
Category:
Microorganisms Antibiotics Animal Husbandry Disease Research Antibacterial Disease Research Fields Other Antibiotics Cancer
Target:
5
Target:
Research Areas:
Luspatercept (ACE-536) is a recombinant modified ActRIIB fusion protein that binds with transforming growth factor β superfamily ligands. Luspatercept increases the erythrocyte numbers and promotes maturation of erythroid precursors. Luspatercept binds with GDF11 and inhibits Smad2/3 signaling. Luspatercept can be used for the research of anemia .
5
5 Cited Publications
Cat. No.: HY-17638
CAS No.: 666843-10-3
Synonyms: DSP-3235 free base; KGA-3235 free base; GSK-1614235 free base
Target:
Research Areas:
Mizagliflozin (DSP-3235 free base) is a potent, orally active and selective SGLT1 inhibitor, with a Ki of 27 nM for human SGLT1. Mizagliflozin displays 303-fold selectivity over SGLT2. Mizagliflozin is used as an antidiabetic agent that can modify postprandial blood glucose excursion. Mizagliflozin also exhibits potential in the amelioration of chronic constipation .
4
Target:
4
Category:
Rutaceae Extract Flavonoids Neurological Disease Flavones Plants Disease Research Fields Citrus Cancer
Target:
4
4 Cited Publications
Cat. No.: HY-52101A
CAS No.: 821794-92-7
Target:
Research Areas:
FMK is a an irreversible RSK2 kinase inhibitor, that covalently modifies the C-terminal kinase domain of RSK.
3
Category:
Rutaceae Extract Triterpenes Terpenoids Metabolic Disease Plants Disease Research Fields Citrus
Target:
3
3
3
3 Cited Publications
Synonyms: (2R)-Octyl-2-HG
Target:
Research Areas:
(2R)-Octyl-α-hydroxyglutarate ((2R)-Octyl-2-HG) is a modified form of D-isomer 2-Hydroxyglutarate.
-
-
Protocols
Targeted therapy! The Capetin Prize winning "Click Chemistry" can be used like this!Targeted therapy! The Nobel Prize winning "Click Chemistry" can be used like this!A suitable model is crucial in drug screening experiments. Organs can mimic the three-dimensional functional structure of internal organs, have similar spatial organization to corresponding organs, maintain some key characteristics, and reproduce some physiological functions. They are widely used for modeling and personalized drug screening physiological functions.2025-02-06
